Zhejiang Huahai Pharmaceutical Co., Ltd.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Public
- Established
- 2001-02-28
- Employees
- 8.2K
- Market Cap
- -
- Website
- https://www.huahaipharm.com
Tolerability and Pharmacokinetics of Hypidone Hydrochloride in Healthy Subjects
Phase 1
Completed
- Conditions
- Major Depressive Disorder
- Interventions
- Drug: Hypidone Hydrochloride tabletsDrug: Placebo
- First Posted Date
- 2020-10-22
- Last Posted Date
- 2021-08-25
- Lead Sponsor
- Zhejiang Huahai Pharmaceutical Co., Ltd.
- Target Recruit Count
- 36
- Registration Number
- NCT04598607
- Locations
- 🇨🇳
Shanghai Mental Health Center, Shanghai, Shanghai, China
Study to Explore the Effective Doses and to Assess the Safety and Efficacy of Hypidone Hydrochloride Tablets
Phase 2
Completed
- Conditions
- Major Depressive Disorder
- Interventions
- Drug: Hypidone Hydrochloride tabletsOther: Placebo
- First Posted Date
- 2018-11-14
- Last Posted Date
- 2020-10-30
- Lead Sponsor
- Zhejiang Huahai Pharmaceutical Co., Ltd.
- Target Recruit Count
- 240
- Registration Number
- NCT03739632
- Locations
- 🇨🇳
Beijing Anding Hospital, Capital Medical University, Beijing, Beijing, China
🇨🇳Beijing Huilongguan Hospital, Beijing, Beijing, China
🇨🇳Hebei Mental Health Center, Baoding, Hebei, China
To Explore the Safety and Efficacy of Hypidone Hydrochloride Tablets in Treatment of Patients With MDD
Phase 1
Completed
- Conditions
- Major Depressive Disorder
- Interventions
- Drug: Hypidone Hydrochloride tablets
- First Posted Date
- 2018-01-19
- Last Posted Date
- 2020-10-30
- Lead Sponsor
- Zhejiang Huahai Pharmaceutical Co., Ltd.
- Target Recruit Count
- 42
- Registration Number
- NCT03404466
- Locations
- 🇨🇳
Shanghai mental health center, Shanghai, Shanghai, China
© Copyright 2025. All Rights Reserved by MedPath